Published on:

FDA reverses its morphine painkiller decision

According to the FDA and its latest product liability news, a liquid morphine painkiller given to dying patients can remain on the market. Last week, the FDA had announced last week that it was ordering manufacturers to stop making 14 medications including the liquid morphine. Last week, however, the FDA told the AP that the morphine liquid will remain on the market until it is replaced by an approved version or equivalent therapy.

To read more about the FDA’s reversal.